Sort
82,697 grants matching “vaccine development”
Nonhuman Primate Reagent Resource
$1,769,004Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2018 · AI
Nonhuman Primate Reagent Resource
$1,769,004Keith A Reimann · Univ Of Massachusetts Med Sch Worcester · U24 · FY2017 · AI
Nonhuman Primate Reagent Resource
$1,769,004Diogo Magnani · Univ Of Massachusetts Med Sch Worcester · U24 · FY2020 · AI
Epithelial innate signaling in airway inflammation and remodeling
$1,767,677Roberto P Garofalo · University Of Texas Med Br Galveston · P01 · FY2018 · AI
Early life respiratory viral infections shape immune development trajectories
$1,767,642Octavio Ramilo · St. Jude Children'S Research Hospital · U19 · FY2023 · AI
ISS-linked NP vaccine to control pandemic flu outbreak
$1,767,169Gary A Van Nest · Dynavax Technologies Corporation · U01 · FY2006 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$1,767,160Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
DNA Vaccine for Induction of Mucosal Immunity
$1,767,044David B. Weiner · University Of Pennsylvania · P01 · FY2009 · AI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
$1,766,851Ren Sun · University Of California Los Angeles · P01 · FY2018 · CA
NCI-Frederick Support and Technical Services
$1,766,692Douglas R. Lowy · Office Of The Director, Nci · ZIC · FY2016 · CA
Immunotherapy with High Frequency, CEA Specific T Cells
$1,766,526Herbert Kim Lyerly · Duke University · P01 · FY2007 · CA
International Studies Of Acquired Immune Deficiency Syndrome (AIDS)
$1,765,808Thomas Quinn · Niaid Extramural Activities · Z01 · FY2007 · AI
Subcellular protein localization in B. subtilis
$1,765,670Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Host Defense Against HIV-related Pulmonary Infections
$1,765,037Judd E Shellito · Lsu Health Sciences Center · P01 · FY2015 · HL
SOFT TISSUE SARCOMA PROGRAM PROJECT
$1,764,115Sloan-Kettering Institute For Cancer Res · P01 · FY2003 · CA
SARS Coronavirus: Inhibition of Entry
$1,764,074Kathryn V Holmes · University Of Colorado Denver · P01 · FY2006 · AI
Immunotherapy with High Frequency, CEA Specific T Cells
$1,763,593Duke University · P01 · FY2005 · CA
Vaccine Production Core
$1,763,524Thomas N Denny · Duke University · U19 · FY2007 · AI
Novel approaches for vaccine design
$1,763,339Michel C Nussenzweig · Rockefeller University · P01 · FY2010 · AI
Integrative analysis and modeling of human immune responses and pathologies
$1,763,154John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
DRW HIV-Ab/HBsAg Duplex Rapid Test submission for FDA-PMA approval
$1,762,981Helen H Lee · Diagnostics For The Real World, Ltd · R44 · FY2008 · HL
Mayo Clinic Ovarian Cancer SPORE
$1,762,703Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2021 · CA
University of Rochester HIV/AIDS Clinical Trials Unit
$1,762,495Michael C Keefer · University Of Rochester · UM1 · FY2021 · AI
Herpesviruses as Vaccine Vectors for AIDS
$1,762,403David M Knipe · Harvard Medical School · P01 · FY2009 · AI
Molecular Biology of Francisella tularensis Virulence
$1,761,802Michael V Norgard · Ut Southwestern Medical Center · P01 · FY2006 · AI